Hematologic Malignancies The University of Vermont’s hematologic malignancies team specializes in the treatment of the entire spectrum of blood and bone marrow cancers and has expertise in the most cutting-edge treatments available, including cellular therapy. Our nationally renowned oncologists see patients with Our nationally renowned oncologists see patients with Body Multiple Myeloma Non-Hodgkin’s Lymphoma Hodgkin’s Lymphoma AL Amyloidosis Myelodysplastic Syndrome Aplastic Anemia Acute Myeloid Leukemia Acute Lymphoid Leukemia Clonal Cytopenia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia A Collaborative Approach A Collaborative Approach Body Your team works collaboratively with other specialists including radiation oncology, surgical oncology, pathology and radiology to provide you access to the advanced interdisciplinary care. Patients receive expert care from a multidisciplinary team that also includes genetic counselors, financial counselors, social workers, nurse navigators, nutritionists, pharmacists, survivorship specialists and rehabilitation medicine specialists. Network Partners and Service Sites Network Partners and Service Sites Body Patients treated at the University of Vermont have access to clinical trials sponsored by the National Cancer Institute and industry, as well as studies initiated by local investigators and physicians. Infusion services for chemotherapy, targeted therapies and immunotherapy are available at UVM Medical Center in Burlington, Central Vermont Medical Center in Berlin, Champlain Valley Physicians’ Hospital in Plattsburgh (NY) and Porter Hospital in Middlebury.